Rippling muscle disease may be caused by "silent" action potentials in the tubular system of skeletal muscle fibers

Muscle and Nerve

Volumn 31, Issue 5, 2005, Pages 652-658

  Lamb, Graham D ^a  

^a LA TROBE UNIVERSITY   (Australia)

Author keywords

Action potential; Caveolin 3; Myotonia; Rippling muscle disease; T system

Indexed keywords

CAVEOLIN 3;

ACTION POTENTIAL; ELECTROMYOGRAM; HUMAN; MUSCLE CELL; MUSCLE CONTRACTION; MUSCLE DISEASE; MUSCLE STRETCHING; MYOTONIA; NONHUMAN; PRIORITY JOURNAL; REVIEW; RIPPLING MUSCLE DISEASE; SKELETAL MUSCLE;

ACTION POTENTIALS; ANIMALS; CAVEOLIN 3; CAVEOLINS; CELL MEMBRANE; HUMANS; MUSCLE CONTRACTION; MUSCLE FIBERS; MUSCLE, SKELETAL; MUSCULAR DISEASES; MUTATION; RATS; REFLEX, STRETCH; STRESS, MECHANICAL;

EID: 17744397526     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.20307     Document Type: Review

References (42)

1. Adrian RH, Peachey LD. Reconstruction of the action potential of frog sartorius muscle. J Physiol (Lond) 1973;235:103-131.
2. Alberca R, Rafel E, Castilla JM, Gil-Peralta A. Increased mechanical muscle irritability syndrome. Acta Neurol Scand 1980;62:250-254.
3. Betz RC, Schoser BGH, Kasper D, Ricker, K, Ramirez A, Stein V, et al. Mutations in CA V3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease. Nat Genet 2001;28:218-219.
4. Bretag AH. Membrane channels and muscle disease. Aust Paediatr J 1988;24(Suppl):50-54.
5. Burns RJ, Bretag AH, Blumbergs PC, Harbord MG. Benign familial disease with muscle mounding and rippling. J Neurol Neurosurg Psychiatry 1994;57:344-347.
6. Fischer D, Schroers A, Blümcke I, Urbach H, Zerres K, Mortier W, et al. Consequences of a novel caveolin-3 mutation in a large German family. Ann Neurol 2003;53:233-241.
7. Flucher BE, Andrews SB. Characterization of spontaneous and action potential-induced calcium transients in developing myotubes in vitro. Cell Motil Cytoskel 1993;25:143-157.
8. Franco-Obregon A, Lansman JB. Mechanosensitive ion channels in skeletal muscle from normal and dystrophic mice. J Physiol (Lond) 1994;481:299-309.
9. Franzini-Armstrong C. Simultaneous maturation of transverse tubules and sarcoplasmic reticulum during muscle differentiation in the mouse. Dev Biol 1991;146:353-363.
10. Franzini-Armstrong C, Jorgensen AO. Structure and development of E-C coupling units in skeletal muscle. Annu Rev Physiol 1994;56:509-534.
11. Galbiati F, Engelman JA, Volonte D, Zhang XL, Minetti C, Li M, et al. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and T-tubule abnormalities. J Biol Chem 2001;276:21425-21433.
12. Hornung K, Nix WA. Myoedema: a clinical and electrophysiological evaluation. Eur Neurol 1992;32:130-133.
13. Jack JJB, Noble D, Tsien RW. Electric current flow in excitable cells. Oxford: Clarendon Press; 1975. 502 p.
14. + channels in muscle surface and T-tubular membranes revealed by tetrodotoxin derivatives. Pflugers Arch 1983;397:1-5.
15. Koul RL, Chand RP, Chacko A, Ali M, Brown KM, Bushnarmuth SR, et al. Severe autosomal recessive rippling muscle disease. Muscle Nerve 2001; 24:1542-1547.
16. Kubisch C, Schoser BGH, Düring MV, Betz RC, Goebel H-H, Zahn S, et al. Homozygous mutations in caveolin-3 cause a severe form of rippling muscle disease. Ann Neurol 2003;53:512-520.
17. 2+ releasing action of caffeine and depolarisation in skeletal muscle fibres of the rat. J Physiol (Lond) 2001;531:715-728.
18. 2+] abolishes excitation-contraction coupling in skeletal muscle fibres of rat and toad. J Physiol (Lond) 1995;489:349-362.
19. 2+] on excitation-contraction coupling in skeletal muscle fibres of the rat. J Physiol (Lond) 1994;478:331-339.
20. Lehmann-Horn F, Jurkat-Rott K. Voltage-gated ion channels and hereditary disease. Physiol Rev 1999;79:1317-1372.
21. Minetti C, Bado M, Broda P, Sotgia F, Bruno C, Galbiati F, et al. Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency. Am J Pathol 2002;160:265-270.
22. Mizusawa H, Takagi A, Sugita H, Toyokura Y. Mounding phenomenon: an experimental study in vitro. Neurology 1983;33:90-93.
23. Mutungi G, Edman KAP, Ranatunga KW. A mechanical stretch induces contractile activation in unstimulated developing rat skeletal muscle in vitro. J Physiol (Lond) 2003;551:93-102.
24. Nakajima S, Gilai A. Radial propagation of muscle action potential along the tubular system examined by potential-sensitive dyes. J Gen Physiol 1980;76:751-762.
25. + pump activity. J Physiol (Lond) 2004;557:133-146.
26. Padmanabhan N, Huang CLH. Separation of tubular electrical activity in amphibian skeletal muscle through temperature change. Exp Physiol 1990;75:721-724.
27. Parton RG, Way M, Zorzi N, Stang E. Caveolin-3 associates with developing T-tubules during muscle differentiation. J Cell Biol 1997;136:137-154.
28. 2+ release in rat skeletal muscle fibres. J Physiol (Lond) 2003;551:219-237.
29. Posterino GS, Lamb GD, Stephenson DG. Twitch and tetanic force responses and longitudinal propagation of action potentials in skinned skeletal muscle fibres of the rat. J Physiol (Lond) 2000;527:131-137.
30. Ralston E, Ploug T. Caveolin-3 is associated with the T-tubules of mature skeletal muscle fibers. Exp Cell Res 1999;246:510-515.
31. Ricker K, Moxley RT, Rohkamm R. Rippling muscle disease. Arch Neurol 1989;46:405-408.
32. Sadeh M, Berg M, Sandbank U. Familial myoedema, muscular hypertrophy and stiffness. Acta Neurol Scand 1990;81:201-204.
33. Sejersted OM, Sjogaard G. Dynamics and consequences of potassium shifts in skeletal muscle and heart during exercise. Physiol Rev 2000;80:1411-1481.
34. Smith DA, Stephenson DG. Theory and observation of spontaneous oscillatory contractions in skeletal myofibrils. J Muscle Res Cell Motil 1994;15:369-389.
35. So YT, Zu L, Barraza C, Figueroa KP, Pulst S-M. Rippling muscle disease: evidence for phenotypic and genetic heterogeneity. Muscle Nerve 2001;24:340-344.
36. Stephenson DG, Lamb GD, Stephenson GMM. Events of the excitation-contraction-relaxation (E-C-R) cycle in fast- and slow-twitch mammalian muscle fibres relevant to muscle fatigue. Acta Physiol Scand 1998;162:229-245.
37. Torbergsen T. Rippling muscle disease: a review. Muscle Nerve 2002;11(Suppl):S103-S107.
38. Vorgerd M, Bolz H, Patzold T, Kubisch C, Malin J-P, Mortier W. Phenotypic variability in rippling muscle disease. Neurology 1999;52:1453-1459.
39. Walker GR, Watkins T, Ansevin CF. Identification of autoantibodies associated with rippling muscles and myasthenia gravis that recognises skeletal muscle proteins: possible relationship of antigens and stretch-activated ion channels. Biochem Biophys Res Commun 1999; 264:430-435.
40. Woodman SE, Sotgia F, Galbiati F, Minetti C, Lisanti MP. Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases. Neurology 2004;62:538-543.
41. Yeung EW, Ballard HJ, Bourreau JP, Allen DG. Intracellular sodium in mammalian muscle fibers after eccentric contractions. J Appl Physiol 2003;94:2475-2482.
42. Yuan S, Arnold W, Jorgensen AO. Biogenesis of transverse tubules and triads: immunolocalization of the 1,4-dihydropyridine receptor, TS28, and the ryanodine receptor in rabbit skeletal muscle developing in situ. J Cell Biol 1991;112:289-301.